24 May 2022
Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, today announced the details...